5 Gastroenterology Headlines You Missed in April 2026

April brought continued momentum in gastroenterology, with advances in inflammatory bowel disease (IBD) research, regulatory activity, and new discussions surrounding the long-term management of irritable bowel syndrome (IBS). From emerging next-generation biologics to evolving treatment strategies in ulcerative colitis and Crohn’s disease, the month highlighted both the pace of innovation in GI care and the ongoing need to address persistent gaps in patient outcomes.